title: Reply to "safety and efficacy of using off-label bevacizumab versus mitomycin C to prevent bleb failure in a single site phacotrabeculectomy by a randomized controlled clinical trial".
authors: Sabyasachi
authors: S
authors: Sengupta
mesh_terms: D000477:Alkylating Agents / Q000008:administration & dosage*; D020533:Angiogenesis Inhibitors / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage*; D003228:Conjunctiva / Q000187:drug effects*; D005260:Female; D006801:Humans; D008297:Male; D016685:Mitomycin / Q000008:administration & dosage*; D018918:Phacoemulsification; D014130:Trabeculectomy
chemical_list: D000477:Alkylating Agents; D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; D016685:Mitomycin